• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胎盘主要蛋白酪氨酸磷酸酶的特性分析

Characterization of the major protein-tyrosine-phosphatases of human placenta.

作者信息

Tonks N K, Diltz C D, Fischer E H

机构信息

Department of Biochemistry, University of Washington, Seattle 98195.

出版信息

J Biol Chem. 1988 May 15;263(14):6731-7.

PMID:2834387
Abstract

In the preceding article (Tonks, N. K., Diltz, C. D., and Fischer, E. H. (1988) J. Biol. Chem. 263, 6722-6730), the purification of the major protein-tyrosine-phosphatases from human placenta, some to apparent homogeneity, was described. This report compares the characteristics of these enzymes and clearly identifies at least two distinct protein-tyrosine-phosphatase catalytic subunits. All were absolutely specific for phosphotyrosyl residues and showed no activity on any of the phosphoseryl/phosphothreonyl-containing proteins tested; they exhibited a high affinity for substrate with Km values in the submicromolar range. All were absolutely dependent on sulfhydryl compounds and appeared to contain at least one highly reactive cysteinyl residue essential for activity. Subtypes 1A and 1B could be distinguished by their response to polyanionic and polycationic compounds. The 1B enzymes were activated by EDTA, spermine, spermidine, and myelin basic protein to a greater extent than the 1A subtypes. Furthermore, they were inhibited by approximately 2 orders of magnitude lower concentrations of heparin (IC50 approximately 20 nM) and 1:1 or 4:1 poly (glutamate/tyrosine) (IC50 approximately 50 nM) than the 1A subtypes. Surprisingly, inhibition by the glutamate/tyrosine copolymers was strictly noncompetitive. Peptide mapping following digestion with Achromobacter protease I or Staphylococcus aureus V8 protease supported the view that, whereas protein-tyrosine-phosphatase subtypes 1A and 1B are different, their soluble and particulate counterparts are closely related structurally and are distinct from serine/threonine phosphatases 1 and 2A.

摘要

在前一篇文章中(汤克斯,N.K.,迪尔茨,C.D.,以及费舍尔,E.H.(1988年)《生物化学杂志》263卷,6722 - 6730页),描述了从人胎盘中纯化主要的蛋白酪氨酸磷酸酶,其中一些已达到表观均一性。本报告比较了这些酶的特性,并明确鉴定出至少两种不同的蛋白酪氨酸磷酸酶催化亚基。所有这些酶对磷酸酪氨酸残基具有绝对特异性,对所测试的任何含磷酸丝氨酸/磷酸苏氨酸的蛋白质均无活性;它们对底物具有高亲和力,米氏常数(Km)值在亚微摩尔范围内。所有这些酶都绝对依赖巯基化合物,并且似乎含有至少一个对活性至关重要的高反应性半胱氨酸残基。1A和1B亚型可通过它们对聚阴离子和聚阳离子化合物的反应来区分。1B型酶比1A亚型更易被乙二胺四乙酸(EDTA)、精胺、亚精胺和髓鞘碱性蛋白激活。此外,与1A亚型相比,它们被肝素(半数抑制浓度(IC50)约为20 nM)和1:1或4:1的聚(谷氨酸/酪氨酸)(IC50约为50 nM)抑制的浓度要低约2个数量级。令人惊讶的是,谷氨酸/酪氨酸共聚物的抑制作用严格来说是非竞争性的。用无色杆菌蛋白酶I或金黄色葡萄球菌V8蛋白酶消化后的肽图谱支持了这样一种观点,即虽然蛋白酪氨酸磷酸酶1A和1B亚型不同,但它们的可溶性和颗粒性对应物在结构上密切相关,并且与丝氨酸/苏氨酸磷酸酶1和2A不同。

相似文献

1
Characterization of the major protein-tyrosine-phosphatases of human placenta.人胎盘主要蛋白酪氨酸磷酸酶的特性分析
J Biol Chem. 1988 May 15;263(14):6731-7.
2
Purification of the major protein-tyrosine-phosphatases of human placenta.人胎盘主要蛋白酪氨酸磷酸酶的纯化
J Biol Chem. 1988 May 15;263(14):6722-30.
3
Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.人胎盘来源的两种主要蛋白酪氨酸磷酸酶亚型对自身磷酸化的胰岛素受体和表皮生长因子受体的去磷酸化作用
Biochem J. 1991 Aug 15;278 ( Pt 1)(Pt 1):69-74. doi: 10.1042/bj2780069.
4
Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes.微量注射低分子量人胎盘蛋白酪氨酸磷酸酶对非洲爪蟾卵母细胞减数分裂细胞分裂诱导的影响。
Mol Cell Biol. 1990 Feb;10(2):458-63. doi: 10.1128/mcb.10.2.458-463.1990.
5
Multiple forms of phosphotyrosyl- and phosphoseryl-protein phosphatase from cardiac muscle: partial purification and characterization of an EDTA-stimulated phosphotyrosyl-protein phosphatase.心肌中多种形式的磷酸酪氨酸和磷酸丝氨酸蛋白磷酸酶:一种受EDTA刺激的磷酸酪氨酸蛋白磷酸酶的部分纯化及特性分析
Arch Biochem Biophys. 1983 Oct 15;226(2):517-30. doi: 10.1016/0003-9861(83)90321-1.
6
Purification and characterization of a higher-molecular-mass form of protein phosphotyrosine phosphatase (PTP 1B) from placental membranes.从胎盘膜中纯化和鉴定高分子量形式的蛋白质酪氨酸磷酸酶(PTP 1B)
Biochem J. 1991 Jun 1;276 ( Pt 2)(Pt 2):315-23. doi: 10.1042/bj2760315.
7
Phosphotyrosine phosphatase activity in human placenta.人胎盘中的磷酸酪氨酸磷酸酶活性。
Jpn J Exp Med. 1985 Feb;55(1):21-7.
8
Purification and characterization of placental membrane phosphotyrosine phosphatases.胎盘膜磷酸酪氨酸磷酸酶的纯化与特性分析
Cold Spring Harb Symp Quant Biol. 1988;53 Pt 1:447-54. doi: 10.1101/sqb.1988.053.01.052.
9
Phosphotyrosyl-protein phosphatases. I. Separation of multiple forms from bovine brain and purification of the major form to near homogeneity.磷酸酪氨酸蛋白磷酸酶。I. 从牛脑中分离多种形式并将主要形式纯化至接近均一性。
J Biol Chem. 1989 May 5;264(13):7747-53.
10
CD45, an integral membrane protein tyrosine phosphatase. Characterization of enzyme activity.CD45,一种整合膜蛋白酪氨酸磷酸酶。酶活性的表征。
J Biol Chem. 1990 Jun 25;265(18):10674-80.

引用本文的文献

1
Theoretical study on the design of allosteric inhibitors of diabetes associated protein PTP1B.糖尿病相关蛋白PTP1B变构抑制剂设计的理论研究
Front Pharmacol. 2024 Aug 22;15:1423029. doi: 10.3389/fphar.2024.1423029. eCollection 2024.
2
Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics.蛋白酪氨酸磷酸酶1B在代谢性疾病和心血管疾病中的作用:从机制到治疗
Front Cardiovasc Med. 2024 Aug 22;11:1445739. doi: 10.3389/fcvm.2024.1445739. eCollection 2024.
3
SHP-1 Variants Broaden the Understanding of pH-Dependent Activities in Protein Tyrosine Phosphatases.
SHP-1变体拓宽了对蛋白质酪氨酸磷酸酶中pH依赖性活性的理解。
JACS Au. 2024 Jul 17;4(8):2874-2885. doi: 10.1021/jacsau.4c00078. eCollection 2024 Aug 26.
4
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases.蛋白酪氨酸磷酸酶 1B(PTP1B):在人类疾病发病机制中的作用的全面综述。
Int J Mol Sci. 2024 Jun 27;25(13):7033. doi: 10.3390/ijms25137033.
5
Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP.蛋白酪氨酸磷酸酶在T细胞中的负调控的免疫治疗意义:PTP1B和TCPTP的新情况
Front Med (Lausanne). 2024 Apr 19;11:1364778. doi: 10.3389/fmed.2024.1364778. eCollection 2024.
6
Sequence - dynamics - function relationships in protein tyrosine phosphatases.蛋白质酪氨酸磷酸酶中的序列-动力学-功能关系
QRB Discov. 2024 Jan 24;5:e4. doi: 10.1017/qrd.2024.3. eCollection 2024.
7
Protein tyrosine phosphatase 1B in metabolic diseases and drug development.蛋白酪氨酸磷酸酶 1B 在代谢性疾病和药物研发中的作用。
Nat Rev Endocrinol. 2024 Jun;20(6):366-378. doi: 10.1038/s41574-024-00965-1. Epub 2024 Mar 22.
8
Measuring the Reversible Oxidation of Protein Tyrosine Phosphatases Using a Modified Cysteinyl-Labeling Assay.使用改良半胱氨酸标记测定法测量蛋白酪氨酸磷酸酶的可逆氧化。
Methods Mol Biol. 2024;2743:223-237. doi: 10.1007/978-1-0716-3569-8_15.
9
Protein Tyrosine Phosphatases: Mighty oaks from little acorns grow.蛋白酪氨酸磷酸酶:万丈高楼平地起。
IUBMB Life. 2023 Apr;75(4):337-352. doi: 10.1002/iub.2716.
10
Insights into the importance of WPD-loop sequence for activity and structure in protein tyrosine phosphatases.深入了解WPD环序列对蛋白质酪氨酸磷酸酶活性和结构的重要性。
Chem Sci. 2022 Oct 26;13(45):13524-13540. doi: 10.1039/d2sc04135a. eCollection 2022 Nov 23.